MedPath
FDA Approval

Clofarabine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Winthrop U.S, a business of sanofi-aventis U.S. LLC
DUNS: 824676584
Effective Date
December 7, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Clofarabine(1 mg in 1 mL)

Manufacturing Establishments6

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Mayne Pharma International Pty Ltd.

Winthrop U.S, a business of sanofi-aventis U.S. LLC

756003745

Genzyme Corporation

Winthrop U.S, a business of sanofi-aventis U.S. LLC

050424395

Pharmachemie B.V.

Winthrop U.S, a business of sanofi-aventis U.S. LLC

402108922

Pfanstiehl, Inc.

Winthrop U.S, a business of sanofi-aventis U.S. LLC

005203476

EUROAPI UK LIMITED

Winthrop U.S, a business of sanofi-aventis U.S. LLC

229522842

Ash Stevens Inc.

Winthrop U.S, a business of sanofi-aventis U.S. LLC

049265333

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Clofarabine

Product Details

NDC Product Code
0955-1746
Application Number
NDA021673
Marketing Category
NDA authorized generic (C73605)
Route of Administration
INTRAVENOUS
Effective Date
December 7, 2023
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 9 mg in 1 mL
Code: 762RDY0Y2HClass: ACTIBQuantity: 1 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath